Alfred W. Sandrock
2014
In 2014, Alfred W. Sandrock earned a total compensation of $8.2M as Group SVP, Chief Medical Officer at Biogen.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $25,042 |
|---|---|
| Non-Equity Incentive Plan | $595,533 |
| Salary | $564,596 |
| Stock Awards | $6,820,257 |
| Other | $163,955 |
| Total | $8,169,383 |
Sandrock received $6.8M in stock awards, accounting for 83% of the total pay in 2014.
Sandrock also received $25K of change in pension value and nonqualified deferred compensation earnings, $595.5K in non-equity incentive plan, $564.6K in salary and $164K in other compensation.
Rankings
In 2014, Alfred W. Sandrock's compensation ranked 745th out of 13,032 executives tracked by ExecPay. In other words, Sandrock earned more than 94.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 745 out of 13,032 | 94th |
Division Manufacturing | 269 out of 4,967 | 95th |
Major group Chemicals And Allied Products | 87 out of 1,690 | 95th |
Industry group Drugs | 68 out of 1,369 | 95th |
Industry Biological Products, Except Diagnostic Substances | 5 out of 241 | 98th |
Source: SEC filing on April 30, 2015.
Sandrock's colleagues
We found seven more compensation records of executives who worked with Alfred W. Sandrock at Biogen in 2014.
2014
George Scangos
Biogen
Chief Executive Officer
2014
Adriana Karaboutis
Biogen
EVP, Technology and Business Solutions
2014
Adam Koppel
Biogen
SVP, Chief Strategy Officer
2014
Douglas Williams
Biogen
Former EVP, Research and Development
2014
Paul Clancy
Biogen
Chief Financial Officer
2014
John Cox
Biogen
EVP, Pharmaceutical Operations and Technology
2014
Stuart Kingsley
Biogen